Navigation Links
West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund
Date:5/14/2010

MERIDEN, Conn., May 14 /PRNewswire/ -- Connecticut waterways may be safer from biomedical waste, thanks to an innovative Community Economic Development Fund small business loan guarantee program. CEDF, with loan-program partners, Connecticut's Department of Economic and Community and the City of West Haven have guaranteed a small business loan to a West Haven company that stems improper disposal of needles and prescription drugs.

West Haven's Pathacura removes area medical waste from health care facilities safely and with a dedication to protecting one of the state's most precious assets, its water. "Pharmaceuticals and personal health care products in the water are a growing national concern; it's important that Connecticut's water is protected from pollutants and chemicals," says Pathacura's Michael Monsillo.

Monsillo's father started Pathacura 15 years ago. The son's been growing the business despite difficult economic conditions. Even as the recession deepened, Pathacura's volume spiked with H1N1 testing and vaccinations. "Pathacura's credit needed development, but we were too small a company to go to a bank for funding," he says.

Monsillo heard about CEDF's micro-finance loan guarantee program at a Rotary Club meeting. CEDF, with the Department of Economic and Community Development and cities of Hartford, Stamford, Bridgeport and West Haven, created the program to mitigate the risk of eligible small businesses. The cities support the small loans with 30 percent guarantees. The program is also partially funded by the Small Business Administration.

Pathacura is using the loan to expand its medical hazardous remediation work for local businesses and public facilities.

"The guarantee programs with our partners enhance CEDF's ability to support small business, particularly start-up or at-risk business and those with little or no collateral," says Donna Wertenbach, CEDF President and CEO. She noted that CEDF can make these loans because 21 banks and other institutions have invested in CEDF's small business, high-risk loan pool.

CEDF was created in 1994 to revitalize Connecticut's distressed neighborhoods by providing greater access to capital, technical assistance to small businesses and support for community economic development. Since then CEDF has provided millions of dollars in loans to small businesses, created and retained thousands of jobs for the state's residents, and funded numerous community planning efforts. Joining forces with the state, leading lenders and representatives from low and moderate income communities, CEDF is helping Connecticut's small businesses and neighborhoods.


'/>"/>
SOURCE CEDF
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... In 1980, Bill Howe opened ... throughout the beach community. His vision to grow the company was built on a ... maintain the highest level of training and customer service. Over 35 years later, Bill ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic apparel company ... second pop-up shop for three consecutive weekends. The pop-up shop is a great ... community, a community full of women who appreciate the most premium goods and ...
(Date:5/25/2016)... ... May 26, 2016 , ... The 12th session of the Silicon ... at HP in Palo Alto, CA. This Bay Area biotech event will focus on ... trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization (CRO) Experien ...
(Date:5/25/2016)... ... May 25, 2016 , ... Furthering its position as ... The National Center for Drug Free Sport (Drug Free Sport®) is excited to expand ... to be held July 12 – 13 in Kansas City, MO, will gather sports ...
(Date:5/25/2016)... ... 25, 2016 , ... One Florida-based plastic surgeon’s enthusiasm is proving to be ... published May 13th on Vanity Fair. In fact, as the article explains, more ... broadcast to more than 800,000 Snapchat fans. Commenting on this trend, Dr. Michael Salzhauer, ...
Breaking Medicine News(10 mins):